CR Pharma IPO - Valuation Is Rich at the Top End
CR Pharmaceutical Group (3220 HK)Â plans to raise US$1,932mm - US$2,321m in its IPO through selling 1,774.6m primary shares.Our fellow insight...
441 Views
CR Pharma Listing: Part 3
China Resources Pharmaceutical Group has filed an Application Proof to list on the HKEX this year, possibly in the current quarter. Our previous...
485 Views
CR Pharma Listing: Part 2
China Resources Pharmaceutical Group has filed an Application Proof to list on the HKEX this year, possibly in the current quarter. Our initial...
398 Views
CR Pharma Listing: Part 1
China Resources Pharmaceutical is one of China’s leading integrated pharmaceuticals companies that manufactures, distributes, and retails...
743 Views
Just What the Doctor Ordered
This is a quick update on Kemp Dolliver's previous insight "Who's Optimistic About Pharmacy's Future in China? China Nepstar's Controlling...
465 Views